USA Financial Formulas’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,115
| Closed | -$991K | – | 368 |
|
|
2024
Q2 | $991K | Sell |
2,115
-2,046
| -49% | -$959K | 0.16% | 71 |
|
|
2024
Q1 | $1.74M | Sell |
4,161
-2,279
| -35% | -$953K | 0.28% | 22 |
|
|
2023
Q4 | $2.62M | Sell |
6,440
-1,224
| -16% | -$498K | 0.46% | 16 |
|
|
2023
Q3 | $2.67M | Sell |
7,664
-2,170
| -22% | -$755K | 3.98% | 1 |
|
|
2023
Q2 | $3.46M | Sell |
9,834
-780
| -7% | -$274K | 5.32% | 1 |
|
|
2023
Q1 | $3.34M | Buy |
+10,614
| New | +$3.34M | 5.42% | 3 |
|
|
2022
Q3 | $3.85M | Sell |
13,295
-792
| -6% | -$229K | 6.07% | 1 |
|
|
2022
Q2 | $3.97M | Buy |
+14,087
| New | +$3.97M | 4.96% | 1 |
|
|
2022
Q1 | – | Sell |
-13
| Closed | -$3K | – | 495 |
|
|
2021
Q4 | $3K | Hold |
13
| – | – | ﹤0.01% | 247 |
|
|
2021
Q3 | $2K | Hold |
13
| – | – | ﹤0.01% | 331 |
|
|
2021
Q2 | $3K | Buy |
13
+3
| +30% | +$692 | ﹤0.01% | 288 |
|
|
2021
Q1 | $2K | Buy |
10
+1
| +11% | +$200 | ﹤0.01% | 280 |
|
|
2020
Q4 | $2K | Sell |
9
-9,067
| -100% | -$2.01M | ﹤0.01% | 242 |
|
|
2020
Q3 | $2.47M | Sell |
9,076
-6,289
| -41% | -$1.71M | 1.86% | 16 |
|
|
2020
Q2 | $4.46M | Buy |
15,365
+696
| +5% | +$202K | 3.32% | 8 |
|
|
2020
Q1 | $3.49M | Buy |
+14,669
| New | +$3.49M | 2.22% | 9 |
|
|
2019
Q1 | – | Sell |
-40,700
| Closed | -$7.85M | – | 353 |
|
|
2018
Q4 | $7.85M | Buy |
+40,700
| New | +$7.85M | 1.95% | 16 |
|
|
2017
Q4 | – | Sell |
-39,969
| Closed | -$6.08M | – | 344 |
|
|
2017
Q3 | $6.08M | Buy |
39,969
+17,099
| +75% | +$2.6M | 1.45% | 12 |
|
|
2017
Q2 | $2.95M | Buy |
+22,870
| New | +$2.95M | 0.71% | 58 |
|